Tumor-suppressive effects of CDK8 in endometrial cancer cells

Cell Cycle

Volumn 12, Issue 6, 2013, Pages 987-999

  Gu, Weiting ^a,b   Wang, Chenguang ^b   Li, Weihua ^a,b   Hsu, Fu Ning ^c   Tian, Lifeng ^b   Zhou, Jie ^b,d   Yuan, Cunzhong ^a   Xie, Xiao Jun ^c   Jiang, Tao ^b,e   Addya, Sankar ^f   Tai, Yanhong ^g   Kong, Beihua ^a   Ji, Jun Yuan ^c  

^a SHANDONG UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c TEXAS A M COLLEGE OF MEDICINE   (United States)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e Qingzhou People's Hospital   (China)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g 90th Hospital of Jinan   (China)

Author keywords

Cell growth; Cell migration; Cyclin dependent kinae 8 (CDK8); Endometrial cancer; Tumorigenesis

Indexed keywords

CYCLIN DEPENDENT KINASE 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84875208009     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.24003     Document Type: Article

References (53)

1. Malumbres M, Harlow E, Hunt T, Hunter T, Lahti JM, Manning G, et al. Cyclin-dependent kinases: a family portrait. Nat Cell Biol 2009; 11:1275-6; PMID:19884882; http://dx.doi.org/10.1038/ncb1109-1275
2. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9:153-66; PMID:19238148; http://dx.doi.org/10. 1038/nrc2602
3. Morgan DO. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997; 13:261-91; PMID:9442875; http://dx.doi.org/10.1146/annurev.cellbio.13.1.261
4. Malumbres M, Barbacid M. Mammalian cyclindependent kinases. Trends Biochem Sci 2005; 30:630-41; PMID:16236519; http://dx.doi.org/10.1016/j.tibs. 2005.09.005
5. Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 2004; 18:2699-711; PMID:15545627; http://dx.doi.org/10.1101/ gad.1256504
6. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, et al. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 2008; 455:547-51; PMID:18794900; http://dx.doi.org/10.1038/nature07179
7. Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010; 468:1105-9; PMID:21179167; http://dx.doi.org/ 10.1038/nature09590
8. Osherovich L. CDK8 is enough in colorectal cancer Science-Business eXchange 2008; 1:5-7; http://dx.doi.org/10.1038/scibx.2008.815
9. Taatjes DJ. The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci 2010; 35:315-22; PMID:20299225; http://dx.doi.org/10.1016/j.tibs.2010.02.004
10. Kornberg RD. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 2005; 30:235-9; PMID:15896740; http://dx.doi.org/10.1016/j. tibs.2005.03.011
11. Conaway RC, Conaway JW. Function and regulation of the Mediator complex. Curr Opin Genet Dev 2011; 21:225-30; PMID:21330129; http://dx.doi.org/10.1016/j. gde.2011.01.013
12. Conaway RC, Sato S, Tomomori-Sato C, Yao T, Conaway JW. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem Sci 2005; 30:250-5; PMID:15896743; http://dx.doi.org/10.1016/j.tibs.2005.03.002
13. Malik S, Roeder RG. Dynamic regulation of pol II transcription by the mammalian Mediator complex. Trends Biochem Sci 2005; 30:256-63; PMID:15896744; http://dx.doi.org/10.1016/j.tibs.2005.03.009
14. Bourbon HM, Aguilera A, Ansari AZ, Asturias FJ, Berk AJ, Bjorklund S, et al. A unified nomenclature for protein subunits of mediator complexes linking transcriptional regulators to RNA polymerase II. Mol Cell 2004; 14:553-7; PMID:15175151; http://dx.doi.org/10.1016/j.molcel.2004.05.011
15. Bourbon HM. Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res 2008; 36:3993-4008; PMID:18515835; http://dx.doi.org/10.1093/nar/gkn349
16. Galbraith MD, Donner AJ, Espinosa JM. CDK8: a positive regulator of transcription. Transcription 2010; 1:4-12; PMID:21327159; http://dx.doi.org/10. 4161/trns.1.1.12373
17. Xu W, Ji JY. Dysregulation of CDK8 and Cyclin C in tumorigenesis. J Genet Genomics 2011; 38:439-52; PMID:22035865; http://dx.doi.org/10.1016/j.jgg.2011. 09.002
18. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 2006; 66:2129-37; PMID:16489013; http://dx.doi.org/10.1158/ 0008-5472.CAN-05-2569
19. Martin ES, Tonon G, Sinha R, Xiao Y, Feng B, Kimmelman AC, et al. Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 2007; 67:10736-43; PMID:18006816; http://dx.doi.org/10.1158/ 0008-5472.CAN-07-2742
20. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H, Barany F, et al. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci USA 2009; 106:7131-6; PMID:19359472; http://dx.doi.org/10.1073/pnas.0902232106
21. Seo JO, Han SI, Lim SC. Role of CDK8 and betacatenin in colorectal adenocarcinoma. Oncol Rep 2010; 24:285-91; PMID:20514474
22. Kim MY, Han SI, Lim SC. Roles of cyclin-dependent kinase 8 and β-catenin in the oncogenesis and progression of gastric adenocarcinoma. Int J Oncol 2011; 38:1375-83; PMID:21344156
23. Firestein R, Shima K, Nosho K, Irahara N, Baba Y, Bojarski E, et al. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival. Int J Cancer 2010; 126:2863-73; PMID:19790197
24. Ji JY, Dyson NJ. Interplay between Cyclin-dependent Kinases and E2F-dependent Transcription. In: Enders G, ed. Cell Cycle Deregulation in Cancer: Springer Science 2010:23-41
25. Brewster CD, Birkenheuer CH, Vogt MB, Quackenbush SL, Rovnak J. The retroviral cyclin of walleye dermal sarcoma virus binds cyclin-dependent kinases 3 and 8. Virology 2011; 409:299-307; PMID:21067790; http://dx.doi.org/10.1016/ j.virol.2010.10.022
26. Rovnak J, Brewster CD, Quackenbush SL. Retroviral cyclin enhances cyclin-dependent kinase-8 activity. J Virol 2012; 86:5742-51; PMID:22379099; http://dx.doi.org/10.1128/JVI.07006-11
27. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010; 463:899-905; PMID:20164920; http://dx.doi.org/10.1038/nature08822
28. Chattopadhyay I, Singh A, Phukan R, Purkayastha J, Kataki A, Mahanta J, et al. Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat Res 2010; 696:130-8; PMID:20083228; http://dx.doi.org/10.1016/j.mrgentox.2010.01.001
29. Mitra AP, Almal AA, George B, Fry DW, Lenehan PF, Pagliarulo V, et al. The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer. BMC Cancer 2006; 6:159; PMID:16780590; http://dx.doi.org/10.1186/1471-2407-6-159
30. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-8; PMID:17344846; http://dx.doi.org/10.1038/nature05610
31. Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, et al. Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 2012; 122:2417-27; PMID:22684109; http://dx.doi.org/10.1172/JCI61462
32. Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, et al. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 2000; 11:533-42; PMID:10880035; http://dx.doi.org/10.1023/A:1008961931534
33. Goodman MT, Hankin JH, Wilkens LR, Lyu LC, McDuffie K, Liu LQ, et al. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997; 57:5077-85; PMID:9371506
34. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006; 17:328-36; PMID:16956771; http://dx.doi.org/10.1016/j.tem.2006.08.006
35. Webb PM. Commentary: weight gain, weight loss, and endometrial cancer. Int J Epidemiol 2006; 35:166-8; PMID:16394116; http://dx.doi.org/10.1093/ije/ dyi301
36. Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, et al. E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 2008; 455:552-6; PMID:18794899; http://dx.doi.org/10.1038/nature07310
37. Zhao J, Ramos R, Demma M. CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation. Oncogene 2012; PMID:22945643; http://dx.doi.org/ 10.1038/onc.2012.364
38. Adler AS, McCleland ML, Truong T, Lau S, Modrusan Z, Soukup TM, et al. CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 2012; 72:2129-39; PMID:22345154; http://dx.doi.org/10.1158/0008-5472. CAN-11-3886
39. Tansey WP. Transcriptional activation: risky business. Genes Dev 2001; 15:1045-50; PMID:11331599; http://dx.doi.org/10.1101/gad.896501
40. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109:1125-31; PMID:11994399
41. Espenshade PJ, Hughes AL. Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 2007; 41:401-27; PMID:17666007; http://dx.doi.org/10.1146/ annurev.genet.41.110306.130315
42. Goldstein JL, Rawson RB, Brown MS. Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys 2002; 397:139-48; PMID:11795864; http://dx.doi.org/10.1006/abbi.2001.2615
43. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 2008; 19:65-73; PMID:18291668; http://dx.doi.org/10.1016/j.tem.2007.10.009
44. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7:763-77; PMID:17882277; http://dx.doi.org/10.1038/nrc2222
45. Meyer KD, Donner AJ, Knuesel MT, York AG, Espinosa JM, Taatjes DJ. Cooperative activity of cdk8 and GCN5L within Mediator directs tandem phosphoacetylation of histone H3. EMBO J 2008; 27:1447-57; PMID:18418385
46. Knuesel MT, Meyer KD, Donner AJ, Espinosa JM, Taatjes DJ. The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol Cell Biol 2009; 29:650-61; PMID:19047373; http://dx.doi.org/10.1128/MCB.00993-08
47. Knuesel MT, Meyer KD, Bernecky C, Taatjes DJ. The human CDK8 subcomplex is a molecular switch that controls Mediator coactivator function. Genes Dev 2009; 23:439-51; PMID:19240132; http://dx.doi.org/10.1101/gad.1767009
48. Donner AJ, Szostek S, Hoover JM, Espinosa JM. CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 2007; 27:121-33; PMID:17612495; http://dx.doi.org/10.1016/j.molcel.2007.05.026
49. Alarcón C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 2009; 139:757-69; PMID:19914168; http://dx.doi.org/10. 1016/j.cell.2009.09.035
50. Fryer CJ, White JB, Jones KA. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 2004; 16:509-20; PMID:15546612; http://dx.doi.org/10.1016/j.molcel.2004.10.014
51. Wang Y, van der Zee M, Fodde R, Blok LJ. Wnt/β-catenin and sex hormone signaling in endometrial homeostasis and cancer. Oncotarget 2010; 1:674-84; PMID:21317462
52. Wang C, Fu M, D'Amico M, Albanese C, Zhou JN, Brownlee M, et al. Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol Cell Biol 2001; 21:3057-70; PMID:11287611; http://dx.doi.org/10.1128/ MCB.21.9.3057-3070.2001
53. Zhou J, Liu Y, Zhang W, Popov VM, Wang M, Pattabiraman N, et al. Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1. J Biol Chem 2010; 285:40342-50; PMID:20956529; http://dx.doi.org/10.1074/jbc.M110.156141